Unknown long-term safety : As its still in development, the long-term safety and efficacy of retatrutide have not been established
Review these questions with your healthcare provider: Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your liver, severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food
Zepbound (tirzepatide) retails for approximately $1,060-1,200/month without insurance
Partial benefits only: A handful of individuals say they just want that mild appetite reduction or mood lift without the fuller experience
Retatrutide is not approved for human use
Only suitable analysis of the relevant sample can provide analytical evidence about that sample